Designed to provide broad exposure to the Small Cap Blend segment of the US equity market, the Schwab U.S. Small-Cap ETF (SCHA) is a passively managed exchange traded fund launched on 11/03/2009. The ...

Stock analysts at StockNews.com initiated coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a ...

Rigel Pharmaceuticals is now reporting net income and has three marketed drugs, all of which can continue to grow. Read more ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at ...

Johnson & Johnson has announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $126.67, along ...

Shares of Johnson & Johnson (JNJ) sold off on news regarding a dilution of its earnings. The selloff ended when it reach ...

In a report released yesterday, Charles Duncan from Cantor Fitzgerald maintained a Hold rating on Intra-Cellular Therapies (ITCI – Research ...

Learn more about whether Intra-Cellular Therapies, Inc. or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ ...

Learn more about whether Corcept Therapeutics Incorporated or Intra-Cellular Therapies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

Below is Validea's guru fundamental report for INTRA-CELLULAR THERAPIES INC (ITCI). Of the 22 guru strategies we follow, ITCI rates highest using our Quantitative Momentum Investor model based on ...